Related Experiment Video
Updated: May 5, 2026

A Rhodopsin Transport Assay by High-Content Imaging Analysis
Published on: January 16, 2019
Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation
Koji M Nishiguchi1, Michael A Sandberg, Aart C Kooijman
1Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA.
Abstract:
The RGS proteins are GTPase activating proteins that accelerate the deactivation of G proteins in a variety of signalling pathways in eukaryotes. RGS9 deactivates the G proteins (transducins) in the rod and cone phototransduction cascades. It is anchored to photoreceptor membranes by the transmembrane protein R9AP (RGS9 anchor protein), which enhances RGS9 activity up to 70-fold. If RGS9 is absent or unable to interact with R9AP, there is a substantial delay in the recovery from light responses in mice. We identified five unrelated patients with recessive mutations in the genes encoding either RGS9 or R9AP who reported difficulty adapting to sudden changes in luminance levels mediated by cones. Standard visual acuity was normal to moderately subnormal, but the ability to see moving objects, especially with low-contrast, was severely reduced despite full visual fields; we have termed this condition bradyopsia. To our knowledge, these patients represent the first identified humans with a phenotype associated with reduced RGS activity in any organ.
Insights
RGS9 and R9AP proteins are crucial for vision. Mutations in these genes cause bradyopsia, a condition characterized by impaired light adaptation and reduced ability to see moving objects.
Area of Science:
- Molecular Biology
- Neuroscience
- Ophthalmology
Background:
- Regulator of G protein signaling (RGS) proteins modulate eukaryotic signaling pathways.
- RGS9, anchored by RGS9 anchor protein (R9AP), is vital for phototransduction in rod and cone cells.
- Deficiency in RGS9-R9AP interaction delays light response recovery in mice.
Purpose of the Study:
- To investigate the human phenotype associated with mutations in RGS9 or R9AP genes.
- To identify the genetic basis for visual impairments related to phototransduction.
Main Methods:
- Genetic analysis of five unrelated patients with visual deficits.
- Clinical examination including visual acuity, visual fields, and contrast sensitivity assessment.
- Phenotypic correlation with RGS9 and R9AP gene mutations.
Main Results:
- Identified five patients with recessive mutations in RGS9 or R9AP.
- Patients exhibited bradyopsia: difficulty adapting to luminance changes and poor low-contrast motion detection.
- Standard visual acuity and visual fields were largely preserved.
Conclusions:
- Human mutations in RGS9 or R9AP cause bradyopsia, a novel visual disorder.
- This study identifies the first human phenotype linked to reduced RGS protein activity in any organ.
- Highlights the critical role of RGS9-R9AP in cone-mediated visual adaptation and motion perception.
Related Concept Videos
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Activation and Inactivation of G Proteins
Anatomy of the Eyeball
Photoreceptors and Visual Pathways

